Drug Pipeline

Nogapendekin Alfa Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
10
Active Studies
4
Recruiting
1
Phase 3
6
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-23 NCT07355205
First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients…
date change Primary completion pushed: 2032-03-31 -> 2032-06-30
2026-05-23 NCT07355205
First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients…
date change Completion pushed: 2032-03-31 -> 2032-06-30
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-04 NCT07628062 Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 2/3
1
Phase 2
6
Phase 1
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT05096663 Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus… Advanced Lung Non-Small Cell Carcinoma Active, Not Recruiting
Phase 2
NCT07123727 A Study to Examine Anktiva for the Treatment of COVID-19. Long COVID Recruiting
NCT07085338 A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy… Neuroblastoma Recurrent Recruiting
NCT07578558 NAI for Sepsis With Persistent Lymphopenia Sepsis Not Yet Recruiting
NCT07355205 First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients… Non-small Cell Lung Cancer Stage IV Not Yet Recruiting
NCT05419011 Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome Colorectal Carcinoma Active, Not Recruiting
NCT07628062 Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal… HPV-Positive Oropharyngeal Squamous Cell Carcinoma Not Yet Recruiting
Phase 1
NCT05618925 Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma Non Hodgkin's Lymphoma Refractory/Relapsed Recruiting
NCT07488884 Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept… Pancreatic Cancer Resectable Not Yet Recruiting
Early Phase 1
NCT07261657 N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma… Myxoid Liposarcoma Recruiting
Sponsors Running Nogapendekin Alfa Trials
Disease Areas
Get alerts when Nogapendekin Alfa trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free